Centene Corp
CNC: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| >$ | LOCK|Ng | LOCK|W#KrXR |
Centene Earnings: Commercial Margin Improvement Boosts 2026 Outlook
Centene reported second-quarter results that included 4% premium revenue growth, a medical cost ratio improvement of over 300 basis points, and adjusted EPS of $2.51, well above FactSet consensus of $1.08 and the loss generated in the prior-year period. Management also raised its 2026 outlook.
